Not applicableEnded earlyNCT01954576What this trial is testingNovoTTF Therapy in Treating Patients With Recurrent Glioblastoma MultiformeWho this might be right forGlioblastomaBrain Neoplasms University of Florida 21
Testing effectiveness (Phase 2)Ended earlyNCT01836549What this trial is testingImetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic EpendymomaAstrocytoma, Grade II+6 more Pediatric Brain Tumor Consortium 43
Testing effectiveness (Phase 2)Ended earlyNCT00014443What this trial is testingTopotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Rush University Medical Center 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05540275What this trial is testingTislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent GlioblastomaWho this might be right forRecurrent Glioblastoma Henan Provincial People's Hospital 30
Large-scale testing (Phase 3)Ended earlyNCT03149575What this trial is testingVAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBMWho this might be right forGlioblastoma MultiformeGlioblastomaGlioma+2 more DelMar Pharmaceuticals, Inc. 2
Testing effectiveness (Phase 2)Study completedNCT02626364What this trial is testingStudy of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene AmplificationWho this might be right forRecurrent/Refractory Glioblastoma Arog Pharmaceuticals, Inc. 11
Early research (Phase 1)Study completedNCT00019019What this trial is testingCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasWho this might be right forBrain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Active Not RecruitingNCT03389802What this trial is testingPhase I Study of APX005M in Pediatric Central Nervous System TumorsWho this might be right forGlioblastoma MultiformeHigh-grade Astrocytoma Not Otherwise Specified (NOS)CNS Primary Tumor, Not Otherwise Specified (NOS)+3 more Pediatric Brain Tumor Consortium 32
Early research (Phase 1)Ended earlyNCT02255461What this trial is testingPalbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsWho this might be right forChildhood Choroid Plexus TumorChildhood EpendymoblastomaChildhood Grade III Meningioma+16 more Pediatric Brain Tumor Consortium 35
Early research (Phase 1)Study completedNCT00098761What this trial is testingVNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain TumorsWho this might be right forBrain and Central Nervous System Tumors Pediatric Brain Tumor Consortium 42
Early research (Phase 1)Looking for participantsNCT07193628What this trial is testingB7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory GlioblastomaWho this might be right forRefractory GlioblastomaRecurrent Glioblastoma Second Affiliated Hospital, School of Medicine, Zhejiang University 14
Early research (Phase 1)UnknownNCT04385173What this trial is testingPilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory GlioblastomaWho this might be right forRecurrent GlioblastomaRefractory Glioblastoma Second Affiliated Hospital, School of Medicine, Zhejiang University 12
Large-scale testing (Phase 3)Ended earlyNCT00761280What this trial is testingEfficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary GlioblastomaWho this might be right forAnaplastic AstrocytomaGlioblastoma Isarna Therapeutics GmbH 27
Testing effectiveness (Phase 2)UnknownNCT04674527What this trial is testingPilot Study of Elemene in Treating Patients With Refractory GlioblastomaWho this might be right forRefractory Glioblastoma Second Affiliated Hospital, School of Medicine, Zhejiang University 30
Testing effectiveness (Phase 2)Study completedNCT01866449What this trial is testingProspective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma MultiformeWho this might be right forGlioblastoma Multiforme (GBM) WHO Grade IV University of Ulm 24
Testing effectiveness (Phase 2)UnknownNCT01737346What this trial is testingProcarbazine and Lomustine in Recurrent GlioblastomaWho this might be right forRecurrent Glioblastoma Multiforme Incheon St.Mary's Hospital 52
Testing effectiveness (Phase 2)Ended earlyNCT01517776What this trial is testingCilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and AdolescentsWho this might be right forGliomas Martin-Luther-Universität Halle-Wittenberg 28
Early research (Phase 1)Study completedNCT03603379What this trial is testingDoxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade GliomasWho this might be right forGlioblastoma University Hospital, Basel, Switzerland 9
Testing effectiveness (Phase 2)Study completedNCT01349660What this trial is testingCombination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma MultiformeWho this might be right forGlioblastoma Multiforme SCRI Development Innovations, LLC 88
Testing effectiveness (Phase 2)Ended earlyNCT00003535What this trial is testingAntineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade GliomaWho this might be right forHigh Grade Glioma Burzynski Research Institute 9